Brokerages Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Target Price at $13.19

Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Free Report) has been given a consensus recommendation of “Reduce” by the fourteen analysts that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $12.63.

A number of research analysts have weighed in on the stock. Jefferies Financial Group dropped their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Royal Bank of Canada boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Bank of America boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Finally, Truist Financial dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st.

Read Our Latest Stock Report on WBA

Walgreens Boots Alliance Stock Down 2.4 %

Walgreens Boots Alliance stock opened at $10.79 on Friday. Walgreens Boots Alliance has a fifty-two week low of $8.08 and a fifty-two week high of $22.47. The stock has a market cap of $9.32 billion, a PE ratio of -1.05, a price-to-earnings-growth ratio of 1.21 and a beta of 0.65. The firm’s 50-day simple moving average is $10.36 and its 200 day simple moving average is $9.71. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same period in the previous year, the company earned $0.66 earnings per share. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. Research analysts predict that Walgreens Boots Alliance will post 1.6 EPS for the current fiscal year.

Institutional Trading of Walgreens Boots Alliance

Institutional investors have recently modified their holdings of the business. First Financial Corp IN increased its holdings in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares during the period. Golden State Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Riverview Trust Co increased its holdings in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after acquiring an additional 1,590 shares during the period. Colonial Trust Co SC increased its holdings in Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock worth $27,000 after acquiring an additional 1,297 shares during the period. Finally, Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $28,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Company Profile

(Get Free Report

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.